| answer text |
<p> </p><p>It does. Public health expertise is contributed to the New Psychoactive
<br>Substances review by:<br><br>Dr Owen Bowden Jones, Consultant in Addiction Psychiatry,
who is leading an <br>initiative to develop clinical knowledge summaries for New Psychoactive
<br>Substances with support from Public Health England; Paul Griffiths, Head of <br>Science
at the European Monitoring Centre for Drugs and Drug Addiction, who <br>received an
award from the US National Institute for Drug Addiction in <br>recognition of his
role in developing the knowledge base on NPS; and the drug <br>policy team at the
Department of Health.</p><p> </p><p> </p>
|
 |
